These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 28426171

  • 21. Blood cytotoxic/inflammatory mediators in non-eosinophilic asthma.
    Hodge S, Hodge G, Simpson JL, Yang IA, Upham J, James A, Gibson PG, Reynolds PN, AMAZES Study Research Group.
    Clin Exp Allergy; 2016 Jan; 46(1):60-70. PubMed ID: 26767492
    [Abstract] [Full Text] [Related]

  • 22. Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis.
    Dorman SC, Efthimiadis A, Babirad I, Watson RM, Denburg JA, Hargreave FE, O'Byrne PM, Sehmi R.
    Am J Respir Crit Care Med; 2004 Mar 01; 169(5):573-7. PubMed ID: 14630618
    [Abstract] [Full Text] [Related]

  • 23. Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Li N, Qiu R, Yang Z, Li J, Chung KF, Zhong N, Zhang Q.
    Respir Med; 2017 Oct 01; 131():192-198. PubMed ID: 28947029
    [Abstract] [Full Text] [Related]

  • 24. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ.
    J Allergy Clin Immunol; 2004 Sep 01; 114(3):575-82. PubMed ID: 15356559
    [Abstract] [Full Text] [Related]

  • 25. Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma.
    Winter NA, Qin L, Gibson PG, McDonald VM, Baines KJ, Faulkner J, Evans TJ, Fricker M.
    J Allergy Clin Immunol; 2021 Aug 01; 148(2):428-438. PubMed ID: 33609626
    [Abstract] [Full Text] [Related]

  • 26. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils.
    Veen JC, Smits HH, Ravensberg AJ, Hiemstra PS, Sterk PJ, Bel EH.
    Am J Respir Crit Care Med; 1998 Oct 01; 158(4):1134-41. PubMed ID: 9769272
    [Abstract] [Full Text] [Related]

  • 27. Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD.
    Chou KT, Su KC, Hsiao YH, Huang SF, Ko HK, Tseng CM, Su VY, Perng DW.
    Arch Bronconeumol; 2017 Oct 01; 53(10):547-553. PubMed ID: 28438346
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Full blood count parameters for the detection of asthma inflammatory phenotypes.
    Zhang XY, Simpson JL, Powell H, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Lin JT, Gibson PG.
    Clin Exp Allergy; 2014 Sep 01; 44(9):1137-45. PubMed ID: 24849076
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prediction of airway inflammation in patients with asymptomatic asthma by using lung sound analysis.
    Shimoda T, Nagasaka Y, Obase Y, Kishikawa R, Iwanaga T.
    J Allergy Clin Immunol Pract; 2014 Sep 01; 2(6):727-32. PubMed ID: 25439364
    [Abstract] [Full Text] [Related]

  • 33. [Control of asthma symptoms and cellular markers of inflammation in induced sputum in children and adolescents with chronic asthma].
    Ciółkowski J, Stasiowska B, Mazurek H.
    Pol Merkur Lekarski; 2009 Mar 01; 26(153):178-83. PubMed ID: 19388528
    [Abstract] [Full Text] [Related]

  • 34. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J, Jiang F, Nayeri F, Zetterström O.
    Respir Med; 2007 Jul 01; 101(7):1447-54. PubMed ID: 17379492
    [Abstract] [Full Text] [Related]

  • 35. Absence of airway inflammation in a large proportion of adolescents with asthma.
    Brooks CR, van Dalen CJ, Zacharasiewicz A, Simpson JL, Harper JL, Le Gros G, Gibson PG, Pearce N, Douwes J.
    Respirology; 2016 Apr 01; 21(3):460-6. PubMed ID: 26693952
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inflammatory subtypes in asthma: assessment and identification using induced sputum.
    Simpson JL, Scott R, Boyle MJ, Gibson PG.
    Respirology; 2006 Jan 01; 11(1):54-61. PubMed ID: 16423202
    [Abstract] [Full Text] [Related]

  • 38. Discriminating sputum-eosinophilic asthma: Accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN.
    Khatry DB, Gossage DL, Geba GP, Parker JM, Jarjour NN, Busse WW, Molfino NA.
    J Allergy Clin Immunol; 2015 Sep 01; 136(3):812-814.e2. PubMed ID: 25913197
    [No Abstract] [Full Text] [Related]

  • 39. Enhanced airway sensory nerve reactivity in non-eosinophilic asthma.
    Ali H, Brooks C, Crane J, Beasley R, Holgate S, Gibson P, Pattemore P, Tzeng YC, Stanley T, Pearce N, Douwes J.
    BMJ Open Respir Res; 2021 Nov 01; 8(1):. PubMed ID: 34728474
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial.
    Neighbour H, Boulet LP, Lemiere C, Sehmi R, Leigh R, Sousa AR, Martin J, Dallow N, Gilbert J, Allen A, Hall D, Nair P.
    Clin Exp Allergy; 2014 Apr 01; 44(4):508-16. PubMed ID: 24286456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.